|
|||||
|
|
Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo‐controlled trial |
|
| Authors: | Daniel Weintraub MD Robert A. Hauser MD MBA Jordan J. Elm PhD Fernando Pagan MD Matthew D. Davis PhD Azhar Choudhry MD MBA for the MODERATO Investigators |
| Affiliation: | 1. Departments of Psychiatry and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA;2. University of South Florida, Tampa, Florida, USA;3. Department of Public Health Science, Medical University of South Carolina, Charleston, South Carolina, USA;4. Georgetown University Medical Center, Washington, DC;5. Teva Pharmaceuticals, West Chester, Pennsylvania, USA;6. Teva Pharmaceuticals, Overland Park, Kansas, USA |
| Abstract: | |
| Keywords: | Parkinson's disease mild cognitive impairment MAO rasagiline |